Clinical development of an MGLU2 positive allosteric modulator to treat nicotine addiction

Ended Cooperative Agreement Awarded Last action

Award ID
U01DA051077
Recipient
Awarding agency
Obligated
$26,847,984

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Originally
Funding
  • $22,693,130.08 Federal
  • $4,154,854.00 Non-federal
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$215 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $3,560,198 $0
Amendment $3,560,198 $0
Amendment $3,560,198 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $4,154,854 $0
Amendment $4,154,854 $4,154,854
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Original award $3,703,043 $0
Show all 21

Subawards

Subrecipient Amount Awarded
University Of California, San Diego Dr. Anthenelli and his UCSD lab team have collaborated with investigators at Sanford Burnham Prebys Medical Discovery Institute and Camino Pharma to develop a… $91,621
Camino Pharma LLC The overall objective of this grant application is to advance SBP-9330 into the clinic and determine its safety, tolerability and pharmacokinetic (PK) profile… $1,854,554

Quick answers

Who received award U01DA051077?

U01DA051077 was awarded to Sanford Burnham Prebys Medical Discovery Institute by National Institute on Drug Abuse (National Institutes of Health) on August 15, 2020.

How much is award U01DA051077 worth?

$26,847,984 has been obligated on U01DA051077: $22,693,130 in federal funding and $4,154,854 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login